Key Details
Price
$44.36PE Ratio
14.54Annual ROE
-0.75%Beta
0.54Events Calendar
Next earnings date:
Feb 27, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 01, 2011Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Aristotle Capital Boston, LLC, an investment advisory firm, published its investor letter for the "Small Cap Equity Strategy" for the fourth quarter of 2024. You can download the letter here. The fluctuations observed in 2024 continued into the last quarter, and during this time, value companies did not perform as well as growth companies, according to the Russell 2000 index.
LOS ANGELES, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) concerning whether the board breached its fiduciary duties to shareholders.
ACHC remains well-poised for growth, attributable to sustained demand for behavioral healthcare services, as well as growth initiatives such as acquisitions, bed additions and joint ventures.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company 's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ:ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 30, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Acadia Healthcare losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/acadia-healthcare-company-inc?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=achc&mktm=r You can also contact attorney Jonathan Naji, Esq.
LOS ANGELES, CA / ACCESSWIRE / December 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company 's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.
NEW YORK CITY, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020, and October 18, 2024, inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
FAQ
- What is the primary business of Acadia Healthcare?
- What is the ticker symbol for Acadia Healthcare?
- Does Acadia Healthcare pay dividends?
- What sector is Acadia Healthcare in?
- What industry is Acadia Healthcare in?
- What country is Acadia Healthcare based in?
- When did Acadia Healthcare go public?
- Is Acadia Healthcare in the S&P 500?
- Is Acadia Healthcare in the NASDAQ 100?
- Is Acadia Healthcare in the Dow Jones?
- When was Acadia Healthcare's last earnings report?
- When does Acadia Healthcare report earnings?
- Should I buy Acadia Healthcare stock now?